ΔNp63α and microRNAs: leveraging the epithelial-mesenchymal transition

Andrew J. Stacy; Michael P. Craig; Suraj Sakaram; Madhavi Kadakia

doi:10.18632/oncotarget.13797

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

ΔNp63α and microRNAs: leveraging the epithelial-mesenchymal transition

Andrew J. Stacy, Michael P. Craig, Suraj Sakaram and Madhavi Kadakia _

PDF | HTML | How to cite

Oncotarget. 2017; 8:2114-2129. https://doi.org/10.18632/oncotarget.13797

Metrics: PDF 2179 views | HTML 5613 views | ?

Abstract

Andrew J. Stacy1, Michael P. Craig1, Suraj Sakaram1 and Madhavi Kadakia1

1 Department of Biochemistry and Molecular Biology, Wright State University, Dayton, OH, USA

Correspondence to:

Madhavi Kadakia, email:

Keywords: EMT, p63, miRNA, signaling, biomarker

Received: September 07, 2016 Accepted: November 22, 2016 Published: December 04, 2016

Abstract

The epithelial-mesenchymal transition (EMT) is a cellular reprogramming mechanism that is an underlying cause of cancer metastasis. Recent investigations have uncovered an intricate network of regulation involving the TGFβ, Wnt, and Notch signaling pathways and small regulatory RNA species called microRNAs (miRNAs). The activity of a transcription factor vital to the maintenance of epithelial stemness, ΔNp63α, has been shown to modulate the activity of these EMT pathways to either repress or promote EMT. Furthermore, ΔNp63α is a known regulator of miRNA, including those directly involved in EMT. This review discusses the evidence of ΔNp63α as a master regulator of EMT components and miRNA, highlighting the need for a deeper understanding of its role in EMT. This expanded knowledge may provide a basis for new developments in the diagnosis and treatment of metastatic cancer.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 13797

Publication Alerts

Research Papers:

ΔNp63α and microRNAs: leveraging the epithelial-mesenchymal transition

Abstract